DB
CGON icon

Dmitry Balyasny’s CG Oncology CGON Stock Holding History

Dmitry Balyasny’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
41,311
+27,140
+192% +$1.77M ﹤0.01% 1633
2026
Q1 		$959K Buy
+14,171
New +$803K ﹤0.01% 2096
2024
Q4 		– Sell
-153,814
Closed -$5.8M – 2799
2024
Q3 		$5.8M Buy
153,814
+115,852
+305% +$4.06M 0.01% 1194
2024
Q2 		$1.2M Buy
+37,962
New +$1.32M ﹤0.01% 1719

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dmitry Balyasny's CGON Position: Q2 2026 in Review

Dmitry Balyasny increased its CG Oncology (CGON) stake by 192% in Q2 2026, buying an estimated $1.77M and bringing the position to 41,311 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Dmitry Balyasny first reported a position in CGON in Q2 2024 and has held it in 4 quarters since. The position peaked at $5.8M in Q3 2024. 226 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Dmitry Balyasny held 41,311 shares of CG Oncology worth $2.94M as of Q2 2026.
  • Dmitry Balyasny bought 27,140 CG Oncology shares in Q2 2026, an estimated $1.77M.
  • CG Oncology made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1633 holding.
  • Dmitry Balyasny first reported a position in CG Oncology in Q2 2024 and has held it in 4 quarters since.
  • Dmitry Balyasny's CG Oncology position peaked at $5.8M in Q3 2024.
  • 226 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.